There is overwhelming evidence to suggest that social determinants of health (SDoH) impact the onset and progression of health conditions, the care that patients receive, their access to testing and [...]
Clarify Health is the proud recipient of Frost & Sullivan’s 2021 New Product Innovation Award. Our real-world evidence (RWE) solutions for the life sciences industry were chosen for their ability to [...]
On Tuesday, May 25, 2021 we hosted a workshop on “Using RWE to drive next-level commercial impact.” It was attended by 35 commercial, HEOR, and RWE experts, from over 25 different [...]
Clarify Health launched new applications of its anonymized patient-level social determinants of health (SDoH) insights to help life sciences companies on their patient-first missions. With real-world evidence (RWE) software products, Clarify Growth and Clarify [...]
The challenge of underdiagnoses when launching a rare disease drug There are 7,000 known rare diseases and 95 percent of them do not have any FDA-approved therapeutic. However, with greater [...]